Hematoloji

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Kaynak‎: Blood Adv. 2022;6(3):785-92.

İndeks‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (yeni pencere açar)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (yeni pencere açar)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Kaynak‎: Transfusion 2017;57(9):2189-96.

İndeks‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (yeni pencere açar)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (yeni pencere açar)

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE.

Kaynak‎: Biol Blood Marrow Transplant 2012;18(5):813-7.

İndeks‎: PubMed 22080050

DOI‎: 10.1016/j.bbmt.2011.10.043

https://www.ncbi.nlm.nih.gov/pubmed/22080050 (yeni pencere açar)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (yeni pencere açar)

McQuilten ZK, Higgins AM, Burns K, Chunilal S, Dunstan T, Haysom HE, Kaplan Z, Rushford K, Saxby K, Tahiri R, Waters N, Wood EM.

Kaynak‎: Transfusion 2019;59(11):3386-95.

İndeks‎: PubMed 31664712

DOI‎: 10.1111/trf.15558

https://www.ncbi.nlm.nih.gov/pubmed/31664712 (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Kaynak‎: Transfusion 2015;55(12):2807-15.

İndeks‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (yeni pencere açar)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (yeni pencere açar)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Kaynak‎: Cancer 2013;119(1):107-14.

İndeks‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (yeni pencere açar)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (yeni pencere açar)

Nikolaidi E, Hatzikou M, Geitona M.

Kaynak‎: Cost Eff Resour Alloc 2013;11(1):16.

İndeks‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (yeni pencere açar)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (yeni pencere açar)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Kaynak‎: Support Care Cancer 2012;20(1):159-65.

İndeks‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (yeni pencere açar)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (yeni pencere açar)

Pettigrew M, Garces K, Deuson R, Kassis J, Laroche V

Kaynak‎: J Med Econ 2013;16(2):318-26.

İndeks‎: PubMed 23216012

DOI‎: 10.3111/13696998.2012.756400

https://www.ncbi.nlm.nih.gov/pubmed/23216012 (yeni pencere açar)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (yeni pencere açar)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Kaynak‎: Hematology 2018;23(7):417-22.

İndeks‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (yeni pencere açar)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (yeni pencere açar)

Reitan JF, Kudrik FJ, Fox K, van Breda A, Shreay S, Corey-Lisle PK.

Kaynak‎: J Med Econ 2013;16(5):633-8.

İndeks‎: PubMed 23425291

DOI‎: 10.3111/13696998.2013.778269

https://www.ncbi.nlm.nih.gov/pubmed/23425291 (yeni pencere açar)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (yeni pencere açar)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Kaynak‎: Transfusion 2010;50(2):487-92.

İndeks‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (yeni pencere açar)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (yeni pencere açar)

Stallworth JR, Jerrell JM, Tripathi A.

Kaynak‎: Am J Hematol 2010;85(10):795-7.

İndeks‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (yeni pencere açar)

Increased hospital costs associated with red blood cell transfusion. (yeni pencere açar)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Kaynak‎: Transfusion 2015;55(5):1082-9.

İndeks‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (yeni pencere açar)

KAN TRANSFÜZYONUNA ALTERNATIF YÖNTEMLERIN DÜŞÜK MALIYETI

Hematoloji

Türkçe

Hematoloji

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (yeni pencere açar)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (yeni pencere açar)

Restrictive blood transfusion practices are associated with improved patient outcomes. (yeni pencere açar)

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (yeni pencere açar)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (yeni pencere açar)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (yeni pencere açar)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (yeni pencere açar)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (yeni pencere açar)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (yeni pencere açar)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (yeni pencere açar)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (yeni pencere açar)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (yeni pencere açar)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (yeni pencere açar)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (yeni pencere açar)

Increased hospital costs associated with red blood cell transfusion. (yeni pencere açar)

Hastane İrtibat Heyeti Yerel Temsilcisiyle İletişime Geçin

Tıbbi Bilgilendirme Paketleri

Videolar

Hematoloji

Dilinizi Seçin

Paylaş